Vuong Trieu, CSO, Director at Sorrento Therapeutics, holds 116.20M shares in Oncotelic Therapeutics (Ticker: OTLC), holds 3.01M shares in Sorrento Therapeutics (Ticker: SRNE). Most recently, Vuong Trieu Bought ― shares of Oncotelic Therapeutics on Aug 27, 2024 for an estimated value of 10.00K.
What is the percentage of profitable transactions made by Vuong Trieu?
The percentage of profitable transactions made by Vuong Trieu is 45%.
What is the average return per transaction made by Vuong Trieu?
The average return per transaction made by Vuong Trieu is -12.00%.
What stocks does Vuong Trieu hold?
Vuong Trieu holds: SRNE, OTLC stocks.
What was Vuong Trieu’s latest transaction?
Vuong Trieu latest transaction was an Informative Buy of $10.00K.
What was Vuong Trieu's most profitable transaction?
Vuong Trieu’s most profitable transaction was an Informative Buy of OTLC stock on March 27, 2020. The return on the trade was 42.00%.
What is Vuong Trieu's role in Sorrento Therapeutics?
Vuong Trieu's role in Sorrento Therapeutics is CSO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.